| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/01/2005 | CA2295333C Assaying nucleotides in solution using a fluorescent intensity quenching effect |
| 03/01/2005 | CA2237120C Compositions and methods for producing heterologous polypeptides in pichia methanolica |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 03/01/2005 | CA2114631C N-acetylglucosaminyltransferase v coding sequences |
| 02/28/2005 | CA2479569A1 A novel transposon-like element |
| 02/28/2005 | CA2479474A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same, and uses thereof |
| 02/28/2005 | CA2479446A1 Correlation of the ratio of tp and dpd mrna expression levels in colorectal cancer with disease-free survival in 5-fu treated patients |
| 02/24/2005 | WO2005017521A2 Techniques for recording signals |
| 02/24/2005 | WO2005017200A1 Method of judging inflammatory disease by using single nucleotide polymorphism in galectin-2 gene |
| 02/24/2005 | WO2005017198A2 Surface display expression system |
| 02/24/2005 | WO2005017172A1 Microbial production of l-ascorbic acid |
| 02/24/2005 | WO2005017170A2 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 02/24/2005 | WO2005017169A1 Method of infusing gene in plant material |
| 02/24/2005 | WO2005017168A1 Expression of human milk proteins in transgenic plants |
| 02/24/2005 | WO2005017167A1 Promoter molecules for use in plants |
| 02/24/2005 | WO2005017166A1 Method for the production of a lysate used for cell-free protein biosynthesis |
| 02/24/2005 | WO2005017165A1 Stem cell beacon |
| 02/24/2005 | WO2005017164A1 Vigilant cells |
| 02/24/2005 | WO2005017162A2 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 02/24/2005 | WO2005017159A2 Microbial production of l-ascorbic acid |
| 02/24/2005 | WO2005017158A1 Nucleic acids from rice conferring resistance to bacterial blight disease caused by xanthomonas spp. |
| 02/24/2005 | WO2005017157A1 Methods and means for altering fiber characteristics in fiber-producing plants |
| 02/24/2005 | WO2005017156A1 A NEW CLASS OF α2δ CALCIUM CHANNEL SUBUNITS |
| 02/24/2005 | WO2005017154A1 IMPROVED siRNA MOLECULE AND METHOD OF INHIBITING GENE EXPRESSION WITH THE USE OF THE SAME |
| 02/24/2005 | WO2005017153A2 Methods for synthesis of defined polynucleotides |
| 02/24/2005 | WO2005017152A1 Method of elevating transformation efficiency in plant by adding copper ion |
| 02/24/2005 | WO2005017151A1 End-deficient mutant of ip3 receptor protein inducing apoptosis |
| 02/24/2005 | WO2005017149A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | WO2005017147A1 Process for producing rose with modified color |
| 02/24/2005 | WO2005017145A1 Method of identifying or presuming gene under regulation regulated by functional rna and method of using the same |
| 02/24/2005 | WO2005017141A1 Improved halohydrin dehalogenases and related polynucleotides |
| 02/24/2005 | WO2005017129A1 Phosphoramide and uses thereof |
| 02/24/2005 | WO2005017128A2 Improved reagents for recombinogenic engineering and uses thereof |
| 02/24/2005 | WO2005017127A2 Rna interference compositions and methods |
| 02/24/2005 | WO2005017125A2 Method for isolation and replication of infectious human hepatitis-c virus |
| 02/24/2005 | WO2005017114A2 Method of increasing metabolism and stress tolerance in a plant |
| 02/24/2005 | WO2005017112A2 Methods of inhibiting cancer growth by binding to nuclear receptors |
| 02/24/2005 | WO2005017110A2 Engineered proteases for affinity purification and processing of fusion proteins |
| 02/24/2005 | WO2005017108A2 Soybean selection system based on aec-resistance |
| 02/24/2005 | WO2005017102A2 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 02/24/2005 | WO2005017101A2 Avian adenoassociated virus (aaav) and uses thereof |
| 02/24/2005 | WO2005017098A2 AMPHIPATHIC AND POLYCATIONIC COMPOUNDS FOR DELIVERING siRNA |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016979A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 02/24/2005 | WO2005016971A1 Organic material-immobiling structure and method for production of the same, and peptide and dna therefor |
| 02/24/2005 | WO2005016970A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/24/2005 | WO2005016969A2 Cd20-binding polypeptide compositions |
| 02/24/2005 | WO2005016966A2 Intron fusion proteins, and methods of identifying and using same |
| 02/24/2005 | WO2005016960A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | WO2005016956A1 Method for detecting transient ligand interactions |
| 02/24/2005 | WO2005016955A2 Nogo receptor antagonists |
| 02/24/2005 | WO2005016950A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | WO2005016947A2 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 02/24/2005 | WO2005016504A2 Disruption of acc synthase genes to delay senescence in plants |
| 02/24/2005 | WO2005016414A2 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 02/24/2005 | WO2005016382A1 Antibodies to c-met |
| 02/24/2005 | WO2005016366A2 Method to inhibit the propagation of an undesired cell population |
| 02/24/2005 | WO2005016281A2 Diagnosis and treatment of malignant neoplasms |
| 02/24/2005 | WO2005016274A2 Rnai treatment of eye disease |
| 02/24/2005 | WO2005015990A1 New diabetes type 2 animal model |
| 02/24/2005 | WO2005015988A1 Npc1l1 (npc3) and methods of use thereof |
| 02/24/2005 | WO2005005634A3 siRNA EXPRESSION SYSTEM |
| 02/24/2005 | WO2004113542B1 Methods and means for delaying seed shattering in plants |
| 02/24/2005 | WO2004113388A3 Anti alpha - folate - receptor - tetramer antibodies |
| 02/24/2005 | WO2004111218A3 Method for producing glucoamylases and their uses |
| 02/24/2005 | WO2004111216A3 Phospholipase variants |
| 02/24/2005 | WO2004111182A3 Methods for cloning nucleic acids in a desired orientation |
| 02/24/2005 | WO2004099377A3 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 02/24/2005 | WO2004099247A3 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 02/24/2005 | WO2004093907A3 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents |
| 02/24/2005 | WO2004090145A3 Compounds and methods to enhance raav transduction |
| 02/24/2005 | WO2004083436A3 Novel bt toxin receptors and methods of use |
| 02/24/2005 | WO2004076665A3 Vaccines derived from epithelial cell mucin muc-1 |
| 02/24/2005 | WO2004076627A3 Method of using adenoviral vectors with increased persistence in vivo |
| 02/24/2005 | WO2004072224A3 Detection of ochratoxin a producing fungi |
| 02/24/2005 | WO2004067723A3 Floral development genes |
| 02/24/2005 | WO2004056973A3 Method for chromosomal engineering |
| 02/24/2005 | WO2004048523A3 Modulation of ku86 expression |
| 02/24/2005 | WO2004044136A3 Compositions comprising alternating 2’-modified nucleosides for use in gene modulation |
| 02/24/2005 | WO2004042029A3 Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use |
| 02/24/2005 | WO2004036171A3 Disease detection by digital protein truncation assays |
| 02/24/2005 | WO2004031413A3 Method for diagnosing non-small cell lung cancers |
| 02/24/2005 | WO2004031409A3 Method for diagnosing chronic myeloid leukemia |
| 02/24/2005 | WO2004021871A3 Hcv assay |
| 02/24/2005 | WO2004016220A3 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/24/2005 | WO2004015062A3 Methods and compositions relating to gene silencing |
| 02/24/2005 | WO2004011594A8 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 02/24/2005 | WO2004005459A3 Modifying the control of gene expression behavior by the deletion of connectrons and by the design and addition of synthetic connectrons in prokaryotic, archea and eukaryotic genomes |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003097791A3 Polynucleotide sequences encoding alkaline a-galactosidases and methods of using same |
| 02/24/2005 | WO2003093450A3 Maize clavata3-like polynucleotide sequences and methods of use |
| 02/24/2005 | WO2003074678A3 Modular recombinatorial display libraries |
| 02/24/2005 | WO2003062381A3 Multiply-substituted protease variants |
| 02/24/2005 | WO2003061582A3 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | WO2003037400A3 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | WO2003008627A3 Phenylthiocarbamide (ptc) taste receptor |
| 02/24/2005 | WO2002074237A8 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 02/24/2005 | WO2001000643A3 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase |